Sattva S Neelapu

64PUBLICATIONS
263CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursLiquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

|Sep 25, 2026
Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.

|Jul 16, 2026
Enabling access to talicabtagene autoleucel in relapsed/refractory B-cell malignancies; multicenter real-world evidence on delivery, efficacy and safety.

|Jul 08, 2026
Identification of an optimal absolute lymphocyte count at leukapheresis in patients with lymphoma treated with CART.

|Jun 24, 2026
A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma.

|Oct 16, 2025
Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma.

Sattva S Neelapu, Julio C Chavez, Alison R Sehgal

|Oct 09, 2025
Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapy.

Paolo Strati, Amanda Brandt, Anath C Lionel

Pageof 11

Frequent Collaborators

20 joint publications

Jason Westin

16 joint publications

Sairah Ahmed

13 joint publications

Loretta Nastoupil

12 joint publications

Maria Rodriguez